Euroapi S.A. (LON:0EAP)

Market Cap	269.15M
Revenue (ttm)	760.15M
Net Income (ttm)	-108.00M
Shares Out	n/a
EPS (ttm)	-1.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	492
Average Volume	2,311
Open	3.101
Previous Close	3.106
Day's Range	3.138 - 3.166
52-Week Range	2.278 - 4.510
Beta	0.69
RSI	59.51
Earnings Date	Jul 29, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances....

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2020
• Employees: 3,187
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0EAP

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.

Financial numbers in EUR